. Author manuscript; available in PMC: 2021 Jun 1.

Published in final edited form as: Psychosom Med. 2020 Jun;82(5):454–460. doi: 10.1097/PSY.0000000000000811

Table 4.

Regression models of the relationship between baseline cardiometabolic risk and frontostriatal cerebral blood flow at two-year follow-up

	Model 1	Model 2
Baseline Cardiometabolic Risk	0.06	0.09
	[−.14, 0.26]	[−0.10, 0.29]
Baseline Frontostriatal CBF	0.21 ^*	0.15
	[0.01, 0.41]	[−0.05, 0.35]
Age		−0.15
		[−0.36, 0.05]
Sex		−0.13
		[−0.55, 0.28]
Race		0.48 ^*
		[0.05, 0.92]
Education		0.31 ^**
		[0.09, 0.54]
N	99	99
R²	0.05	0.17

Standardized regression coefficients are reported with the 95% confidence interval below in brackets. Each model is adjusted for frontostriatal cerebral blood flow at baseline. Model 1 is unadjusted for any further covariates. Model 2 is adjusted for age, sex, race, and education. CBF = Cerebral blood flow;

^***

p < 0.001;

^**

p < 0.01;

p < 0.05.